HUTCHMED (China) (HCM) Total Current Liabilities (2015 - 2025)
HUTCHMED (China)'s (HCM) quarterly Total Current Liabilities came in at $315.8 million in Q4 2025, down 7.76% on a QoQ basis from $342.3 million in Q2 2025.
HUTCHMED (China) (HCM) Total Current Liabilities (2015 - 2025) Analysis & Trends
HUTCHMED (China) (HCM) has 11 years of Total Current Liabilities data on file, last reported at $315.8 million in Q4 2025.
- On a quarterly basis, Total Current Liabilities changed N/A year-over-year to $315.8 million in Q4 2025; TTM through Dec 2025 was $315.8 million, a N/A change from a year earlier, with the FY2025 full-year figure at $315.8 million, changed N/A from the prior year.
- Total Current Liabilities for Q4 2025 stood at $315.8 million, down from $342.3 million in the prior quarter.
- Over the last five years, Total Current Liabilities for HCM reached as high as $373.3 million in Q2 2024 and fell as low as $188.5 million in Q1 2021.
- Historically, Total Current Liabilities has averaged $310.7 million across 5 years, with a median of $321.9 million in 2022.
- Across the five-year window, Total Current Liabilities surged 107.49% in 2021 and decreased 8.29% in 2025, its largest moves.
- Year by year, Total Current Liabilities stood at $311.7 million in 2021, then grew by 13.55% to $353.9 million in 2022, then retreated by 3.68% to $340.9 million in 2023, then increased by 9.51% to $373.3 million in 2024, then slipped by 15.41% to $315.8 million in 2025.
- Per Business Quant data, the three most recent Total Current Liabilities figures were $315.8 million in Q4 2025, $342.3 million in Q2 2025, and $373.3 million in Q2 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 6.56 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 13.53 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 2.05 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 18.06 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 599.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 13.17 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 6.81 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 831.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 1.66 Bn |
| 10 | HUTCHMED (China) | 241.90 Mn | 243.61 Mn | - | 315.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 315.78 Mn |
| Jun 30, 2025 | 342.35 Mn |
| Jun 30, 2024 | 373.29 Mn |
| Jun 30, 2023 | 340.86 Mn |
| Dec 31, 2022 | 353.90 Mn |
| Jun 30, 2022 | 321.86 Mn |
| Dec 31, 2021 | 311.66 Mn |
| Jun 30, 2021 | 247.72 Mn |
| Mar 31, 2021 | 188.52 Mn |
| Dec 31, 2020 | 158.40 Mn |
| Jun 30, 2020 | 119.39 Mn |
| Dec 31, 2019 | 113.10 Mn |
| Sep 30, 2019 | 105.35 Mn |
| Jun 30, 2019 | 110.61 Mn |
| Mar 31, 2019 | 101.33 Mn |
| Dec 31, 2018 | 85.48 Mn |
| Jun 30, 2018 | 84.58 Mn |
| Dec 31, 2017 | 104.60 Mn |
| Jun 30, 2017 | 96.84 Mn |
| Dec 31, 2016 | 95.12 Mn |